Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2009, Vol. 3 Issue (3) : 287-291    https://doi.org/10.1007/s11684-009-0050-5
Research articles
Lentivector-mediated RNAi efficiently downregulates expression of murine cdk4 gene
Feng JIANG PhD 1, Xuezhen WANG PhD 2, Zheng XUE MD 2, Suming ZHANG PhD 2, Siyu FANG BM 2, Min ZHANG MD, PhD 2,
1.Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;Department of Neurology, Inner Mongolia Hospital, Hohhot 010017, China; 2.Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;
 Download: PDF(158 KB)  
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract In order to explore the role of cyclin-dependent kinase 4 (cdk4) in neurodegenerative diseases, lentiviral-delivered RNA interference (RNAi) was used to silence the expression of the murine cdk4 gene in vitro. Three cdk4-shRNAs of mouse and a negative sequence were designed. After synthesis and annealing, double strand oligonucleotides were cloned into a linearized pSIH1-H1-copGFP shRNA vector. It was confirmed by polymerase chain reaction (PCR) and sequencing that three pairs of cdk4-shRNAs and a negative shRNA were correctly inserted into the pSIH1-H1-copGFP vector. The above recombinants were transfected by lipofectamine into BV-2 cells. The gene silencing efficacy rates of the 3 targets were compared by Western blotting. The cdk4-siRNA2 was the most effective in silencing cdk4. The optimized pSIH1-cdk4-siRNA2 and pSIH-negative-siRNA were co-transfected into 293T cells with the lentiviral packaging plasmids respectively. The culture supernatant was harvested and condensed at the 24th and 48thh after transfection. Interference efficiency of the lentivirus expressing cdk4-siRNA was determined by reverse transcriptase-PCR (RT-PCR) and Western blotting in BV-2 cells. Lentivector-mediated RNAi could efficiently down-regulate the expression of the murine cdk4 gene in vitro, which provides a potential tool for studying and treating cdk4-related diseases.
Keywords cyclin-dependent kinase 4      RNA interference      plasmid      lentiviral vector      
Issue Date: 05 September 2009
 Cite this article:   
Feng JIANG PhD,Xuezhen WANG PhD,Zheng XUE MD, et al. Lentivector-mediated RNAi efficiently downregulates expression of murine cdk4 gene [J]. Front. Med., 2009, 3(3): 287-291.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0050-5
https://academic.hep.com.cn/fmd/EN/Y2009/V3/I3/287
Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof P R. Tau protein isoforms, phosphorylationand role in neurodegenerative disorders. Brain Res Brain Res Rev, 2000, 33(1): 95―130

doi: 10.1016/S0165-0173(00)00019-9
Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park D S. Involvement of cell cycle elements, cyclin-dependentkinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem, 1999, 274(27): 19011―19016

doi: 10.1074/jbc.274.27.19011
Vincent I, Pae C I, Hallows J L. The cell cycle and human neurodegenerative disease. Prog Cell Cycle Res, 2003, 5: 31―41
Smith P D, O'Hare M J, Park D S. Emerging pathogenic role for cyclin dependent kinasesin neurodegeneration. Cell Cycle, 2004, 3(3): 289―291
Jorda E G, Verdaguer E, Canudas A M, Jiménez A, Bruna A, Caelles C, Bravo R, Escubedo E, Pubill D, Camarasa J, Pallàs M, Camins A. Neuroprotectiveaction of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-inducedapoptosis. Neuropharmacology, 2003, 45(5): 672―683

doi: 10.1016/S0028-3908(03)00204-1
Elbashir S M, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interferencein cultured mammalian cells. Nature, 2001, 411(6836): 494―498

doi: 10.1038/35078107
Wilda M, Fuchs U, Wössmann W, Borkhardt A. Killingof leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene, 2002, 21(37): 5716―5724

doi: 10.1038/sj.onc.1205653
Jacque J M, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature, 2002, 418(6896): 435―438

doi: 10.1038/nature00896
Shlomai A, Shaul Y. Inhibition of hepatitis Bvirus expression replication by RNA interference. Hepatology, 2003, 37(4): 764―770

doi: 10.1053/jhep.2003.50146
Cann A J. RNA viruses. A practical approach. Oxford: OxfordUniversity Press, 2000
Albertin G, Ruggero M, Guidolin D, Nussdorfer G G. Gene silencing of human RAMP2 mediated by short-interfering RNA. Int J Mol Med, 2006, 18(4): 531―535
Abbas-Terki T, Blanco-Bose W, Déglon N, Pralong W, Aebischer P. Lentiviral-mediated RNA interference. Hum Gene Ther, 2002, 13(18): 2197―2201

doi: 10.1089/104303402320987888
Hommel J D, Sears R M, Georgescu D, Simmons D L, DiLeone R J. Local gene knockdown in thebrain using viral-mediated RNA interference. Nat Med, 2003, 9(12): 1539―1544

doi: 10.1038/nm964
Stewart S A, Dykxhoorn D M, Palliser D, Mizuno H, Yu E Y, An D S, Sabatini D M, Chen I S, Hahn W C, Sharp P A, Weinberg R A, Novina C D. Lentivirus-delivered stable gene silencing by RNAi inprimary cells. RNA, 2003, 9(4): 493―501

doi: 10.1261/rna.2192803
Ong W Y, Kumar U, Switzer R C, Sidhu A, Suresh G, Hu C Y, Patel S C. Neurodegeneration in Niemann-Picktype C disease mice. Exp Brain Res, 2001, 141(2): 218―231

doi: 10.1007/s002210100870
Khatib Z A, Matsushime H, Valentine M, Shapiro D N, Sherr C J, Look A T. Coamplification of the CDK4 gene with MDM2 and GLI inhuman sarcomas. Cancer Res, 1993, 53(22): 5535―5541
Bu B T, Wang X Z, Zhang Y H. Activation of cdk4/cyclin D1 pathway participates inthe neuronal degeneration of murine niemann-pick disease type C. Xi Bao Sheng Wu Xue Za Zhi, 2005, 27(4): 435―440 (in Chinese)
McCaffrey A P, Nakai H, Pandey K, Huang Z, Salazar F H, Xu H, Wieland S F, Marion P L, Kay M A. Inhibitionof hepatitis B virus in mice by RNA interference. Nat Biotechnol, 2003, 21(6): 639―644

doi: 10.1038/nbt824
Smith-Arica J R, Bartlett J S. Gene therapy: recombinantadeno-associated virus vectors. Curr CardiolRep, 2001, 3(1): 43―49

doi: 10.1007/s11886-001-0009-x
Rubinson D A, Dillon C P, Kwiatkowski A V, Sievers C, Yang L, Kopinja J, Rooney D L, Zhang M, Ihrig M M, McManus M T, Gertler F B, Scott M L, Van Parijs L. Alentivirus-based system to functionally silence genes in primary mammaliancells, stem cells and transgenic mice by RNA interference. Nat Genet, 2003, 33(3): 401―406

doi: 10.1038/ng1117
Sinn P L, Sauter S L, McCray P B Jr. Gene therapy progress and prospects: development of improvedlentiviral and retroviral vectors- design, biosafety, and production. Gene Ther, 2005, 12(14): 1089―1098

doi: 10.1038/sj.gt.3302570
Dull T, Zufferey R, Kelly M, Mandel R J, Nguyen M, Trono D, Naldini L. Athird-generation lentivirus vector with a conditional packaging system. J Virol, 1998, 72(11): 8463―8471
Wiznerowicz M, Trono D. Conditional suppression ofcellular genes: lentivirus vector mediated drug-inducible RNA interference. J Virol, 2003, 77(16): 8957―8961

doi: 10.1128/JVI.77.16.8957-8951.2003
Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, Bertsch U, Kretzschmar H. Lentivector-mediated RNAiefficiently suppresses prion protein and prolongs survival of scrapie-infectedmice. J Clin Invest, 2006, 116(12): 3204―3210

doi: 10.1172/JCI29236
Yang Z, Cloud A, Hughes D, Johnson L F. Stable inhibition of human thymidylate synthase expression followingretroviral introduction of an siRNA gene. Cancer Gene Ther, 2006, 13(1): 107―114

doi: 10.1038/sj.cgt.7700880
[1] Hui XIAO PhD, Ming TIAN MM, Junna GE MM, Xin Wei MD, Zhaoming LI MM, Xiaolan LI MS, Deding TAO PhD, Junbo HU MD, Jianping GONG MD, . The role of CDK1 siRNA interference in cell cycle and cell apoptosis[J]. Front. Med., 2009, 3(4): 384-389.
[2] Cuihong ZHENG, Yunxia WU, Guangying HUANG, Wei WANG. Gene silencing efficiency of shRNA expression vectors targeting Cx43 in vitro[J]. Front Med Chin, 2009, 3(2): 130-135.
[3] Zhengjuan LIU, Jie BIAN, Yuchuan WANG, Yongli ZHAO, Dong YAN, Xiaoxia WANG. Construction and identification of lentiviral RNA interference vector of rat leptin receptor gene[J]. Front Med Chin, 2009, 3(1): 57-60.
[4] ZHANG Shilong, ZENG Fuqing, PENG Shibo, WANG Liang. Effect on proliferation and apoptosis of T24 cell lines via silencing DNMT1 with RNA interference[J]. Front. Med., 2008, 2(4): 374-379.
[5] LIU Hongchun, CAO Zhongwei, JIN Jianjun, WANG Jiyao. Blockage of receptor-interacting protein 2 expression by small interfering RNA in murine macrophages[J]. Front. Med., 2008, 2(2): 166-170.
[6] ZHANG Jingqun, SUN Honglei, MA Yexin, WANG Daowen. Effects of RNA interference targeting angiotensin 1a receptor on blood pressure and cardiac hypertrophy of rats with renovascular hypertension[J]. Front. Med., 2008, 2(1): 19-24.
[7] JI Yewei, NIE Bin, LI Ping, ZHOU Yuanguo, XU Xiaoyu. Construction of Hsp90β gene specific silencing plasmid and its transfection efficiency[J]. Front. Med., 2007, 1(3): 253-257.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed